Most of us define our health as above average.
Yet, 97% live with everyday health issues such as e.g. stress, sleep issues and digestive problems*.
Imagine how great life would be if we didn’t have to live with such issues.
So let’s decide not to.
Karo Pharma delivers smart choices that give people control over their everyday healthcare.
*IPSOS “Self Care: Be Your Best” Report, 2019
“The itching has been going for so long, I was starting to accept that this was just my skin.”
– Male, Norway
Probiotics: The natural way to boost your wellbeing
“I noticed my hemorrhoids as an early teen, but didn’t do anything about it for years.”
– Male, UK
“The cortisone cream was a game changer for me. I felt the difference immediately.”
– Male, Norway
1 out of 5 adults live with toenail fungus
– Global Nail Fungus Organization 2019
“We’ve made it our purpose to develop reliable ways for people to treat their everyday ailments, to help them live healthier lives. We call it smart choices for everyday healthcare.”
Christoffer Lorenzen, CEO, Karo Pharma
Karo Pharma acquires Sylphar International NV for EUR 290m and intends to carry out a rights issue of approximately EUR 200-250m
Karo Pharma Aktiebolag (publ) (the ”Company” or ”Karo”) has today entered into an agreement to acquire all of the shares…
Anna Hale appointed CMO at Karo Pharma
Karo Pharma Aktiebolag (publ) (“Karo”) has appointed Anna Hale as the Chief Marketing Officer (CMO) of Karo. The appointment reflects Karo’s growth ambitions, fueled by a…
Magnus Nylén leaves Karo Pharma, Matt Roberts appointed new CCO
Karo Pharma Aktiebolag (“Karo”) has appointed Matt Roberts as the new Chief Commercial Officer (CCO) of Karo, replacing Magnus Nylén…
Karo Pharma Quarterly report Q3 2021
July – September Revenues amounted to MSEK 738.5 (679.1), corresponding to an increase of +9% for the period. The organic…
Interim report Q2 2021
April – June Revenues amounted to MSEK 747.9 (688.9), corresponding to an increase of +9% for the period. The organic…
Interim report Q1 2021
January – March Revenues amounted to MSEK 713.0 (793.6), corresponding to a decrease of -10% for the period. The organic…
We support Operation Smile
Every three minutes, a child with cleft lip or palate is born. These children often live a tough life, having to endure harassment and isolation.
Operation Smile perform about 15,000 surgeries a year – improving the lives of just as many children all over the world. For us this is a smart choice for everyday healthcare and why Karo Pharma has supported Operation Smile since 2018.
You can read more about the medical missions in Malawi, Mozambique and Ghana, which our backing made possible, in our Annual Report.